ly 311727 has been researched along with dinoprostone in 2 studies
Studies (ly 311727) | Trials (ly 311727) | Recent Studies (post-2010) (ly 311727) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
33 | 1 | 6 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | ly 311727 (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dennis, EA; Hua, XY; Lucas, KK; Powell, HC; Svensson, CI; Yaksh, TL | 1 |
Dennis, EA; Kessen, UA; Killermann Lucas, K; Schaloske, RH; Stephens, DL | 1 |
2 other study(ies) available for ly 311727 and dinoprostone
Article | Year |
---|---|
Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2.
Topics: Animals; Blotting, Western; Carrageenan; Dialysis; Dinoprostone; Dose-Response Relationship, Drug; Functional Laterality; Gene Expression Regulation, Enzymologic; Group II Phospholipases A2; Hyperalgesia; Indoles; Inflammation; Inhibition, Psychological; Male; Pain Measurement; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Reaction Time; Spinal Cord; Substance P; Time Factors | 2005 |
PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.
Topics: Animals; Arachidonic Acid; Cell Line; Culture Media; Cyclooxygenase 2; Dinoprostone; DNA, Complementary; Eicosanoids; Enzyme Inhibitors; Group V Phospholipases A2; Immunoblotting; Indoles; Lipids; Lipopolysaccharides; Macrophages; Mice; Oligonucleotides, Antisense; Phospholipases A; Phospholipases A2; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors; Transfection; Up-Regulation | 2005 |